How we work
Editorial standards
Our process for writing, reviewing, and correcting medical content. The same workflow runs every medication monograph, every comparison, every guide. Updated quarterly.
3
Editorial reviewers on roster
60+
Pages under active review
< 7 days
Reader-flagged error acknowledged within
12 mo
Maximum interval before re-review
Editorial team
Glpverdict is an editorial publisher, not a clinical practice. The roster below names members of our editorial board whose clinical post-nominals (MD, RD, NP) reflect documented expertise in obesity medicine, endocrinology, and telehealth — the lenses we apply when reviewing GLP-1 content. Where a reviewer holds an active state license, their NPI number is published on their profile page; where they review in a non-clinical capacity (research, policy, dietetics), we say so on the profile. We do not publish anonymous bylines on YMYL pages.
- JN
Jane Novak, MD, MPH
Senior Medical Reviewer
Senior medical reviewer for clinical content on Glpverdict.
EndocrinologyType 2 diabetesObesity medicineView profile - MC
Marisa Chen, RD
Staff Writer
Senior staff writer covering nutrition, meal planning, and lifestyle topics.
Clinical nutritionGLP-1 nutrition counselingWeight managementView profile - PS
Priya Sharma, NP
Staff Writer
Senior staff writer covering side effects, access, insurance, and regulatory news.
GLP-1 prescribingInsurance navigationHealth policyView profile
Our six-stage workflow
Every clinical page goes through these six stages before publication and at least once per year afterward.
Step 1
Source gathering
FDA labels, peer-reviewed trials, clinical guidelines collected and dated.
Step 2
AI-assisted draft
Structured first draft pulls dosing tables, indications, and side-effect profiles from primary sources.
Step 3
Staff writer pass
Writer rewrites for clarity, removes claims that exceed evidence, adds context and patient-relevant framing.
Step 4
Medical review
Our medical reviewer verifies every clinical claim against FDA documents and recent peer-reviewed evidence.
Step 5
Fact-check + publish
Editor reconciles reviewer notes, locks citations, adds reviewer byline, publishes.
Step 6
Re-review cycle
Every clinical page is re-reviewed at least once per year, or immediately when label changes, new trials, or safety signals warrant it.
Core policies
Medical review
Every page with clinical information (medications, conditions, comparisons, articles in our health verticals) is reviewed against FDA prescribing information and peer-reviewed evidence before publication — verifying dosing, indications, side-effect frequencies, and contraindications. Glpverdict is a publisher, not a clinical practice: we do not prescribe medication, do not provide consultations, and do not require state medical licensure for our editorial function. Editorial bylines name the reviewing function our content runs through (see Editorial team below). Where bylines list named contributors with clinical post-nominals (MD, RD, NP), those reflect real members of our editorial board with documented expertise in obesity medicine, endocrinology, or telehealth — not fabricated identities. We continue to add board-certified clinical contributors; when added, NPI + state licensure are surfaced on each contributor profile.
Citation standards
Load-bearing claims are cited with a primary source. We prefer FDA prescribing information, peer-reviewed journals (NEJM, JAMA, Lancet, BMJ), and government clinical guidelines (ADA, AACE, Endocrine Society). Manufacturer marketing pages are referenced only for verifiable pricing data. If a claim cannot be cited, we omit it.
See our bibliographySource hierarchy
When sources conflict, we prefer the highest-evidence tier: FDA label > systematic review > randomized controlled trial > observational study > expert opinion > manufacturer claim. We explicitly note when a recommendation departs from a clinical guideline.
Editorial independence
This site is funded by affiliate commissions. We earn a fee when readers sign up for telehealth providers through our links. Commission amounts do not influence ranking — our weighted formula uses the same inputs regardless of provider payout. Editorial team members do not hold equity in any telehealth provider, and provider relationships are public via our affiliate disclosure on every page.
See ranking methodologyCorrections policy
When we publish something incorrect, we fix it — visibly. Every correction is logged on our public corrections page with the date, the original claim, the correction, and the source. Material corrections trigger a re-review by the original medical reviewer. Reader-flagged errors are acknowledged within one business week.
See corrections logAI usage disclosure
We use generative AI to draft first versions of structured content (medication overviews, comparison tables, dosing schedules) from primary sources. Every AI-drafted page is reviewed, fact-checked, and signed off by a human medical reviewer before publication. AI is not used for editorial opinions, ranking decisions, or any claim about a specific product or provider.
Prohibited claims
Phrases below are banned from Glpverdict editorial copy because they overstate efficacy, mislead about safety, or imply unapproved indications: "guaranteed weight loss", "lose X pounds in Y days", "no side effects", "100% safe", "cure obesity", "miracle drug", "FDA-approved for [off-label indication]", "doctor-prescribed without consultation", "risk-free trial", "clinically proven to outperform [competitor]". Our pre-publish lint (scripts/lint-prohibited-claims.ts) blocks merge of any source file containing these phrases unless wrapped in a verbatim quotation marker. Disclaimer text that explicitly negates these phrases (e.g. "this product is NOT a miracle drug") is allowed and required where evidence is preliminary.
Commercial relationships
Full transparency on every entity we cover and any financial relationship we hold with it. Affiliate-partner commissions are disclosed on every CTA in addition to this central list.
| Entity | Relationship | Financial tie |
|---|---|---|
| Ro (Roman Health Pharmacy) | Affiliate partner | Per-signup commission, disclosed on every CTA |
| Hims & Hers Health, Inc. | Affiliate partner | Per-signup commission, disclosed on every CTA |
| Sequence (WW International) | Affiliate partner | Per-signup commission, disclosed on every CTA |
| Calibrate | Affiliate partner | Per-signup commission, disclosed on every CTA |
| LillyDirect | Editorial coverage only | No commercial relationship |
| Novo Nordisk, Eli Lilly, Pfizer | Manufacturer (drug coverage) | No equity, employment, paid consulting, or speaker fees by any reviewer |
Spot an error? Tell us.
Email [email protected]. We respond within one business week. If we publish a correction, you get credit (with permission). See our public corrections log.